The need for transparency and good practices in the qPCR literature

Stephen A. Bustin, Vladimı́r Beneš, Jeremy A. Garson, +81

Nature Methods

Good PracticesQuality AssuranceQpcr LiteratureManagementResearch Ethics +2

An Illegitimate microRNA Target Site within the 3′ UTR of <i>MDM4</i> Affects Ovarian Cancer Progression and Chemosensitivity

Jessika Wynendaele, Anja Böhnke, Eleonora Leucci, +17

Cancer Research

Small-Molecule MDM2 Antagonists as a New Therapy Concept for Neuroblastoma

Tom Van Maerken, Frank Speleman, Joëlle Vermeulen, +9

Cancer Research

ApoptosisCell DeathPharmacotherapyGliomaTumor Biology +18

Tpl2/Cot Signals Activate ERK, JNK, and NF-κB in a Cell-type and Stimulus-specific Manner

Santasabuj Das, Jeonghee Cho, Irina Lambertz, +4

Journal of Biological Chemistry

ApoptosisImmunologyCell DeathSynaptic SignalingCellular Physiology +22

Antitumor Activity of the Selective MDM2 Antagonist Nutlin-3 Against Chemoresistant Neuroblastoma With Wild-Type p53

Tom Van Maerken, Liesbeth Ferdinande, Jasmien Taildeman, +12

JNCI Journal of the National Cancer Institute

Microbes exploit death-induced nutrient release by gut epithelial cells

Christopher J. Anderson, Christopher B. Medina, Brady Barron, +15

Nature

Gut Epithelial CellsDysbiosisHost-microbe InteractionsGut MicrobiologyMicrobial Ecology +5

Upregulation of MAPK Negative Feedback Regulators and RET in Mutant ALK Neuroblastoma: Implications for Targeted Treatment

Irina Lambertz, Candy Kumps, Shana Claeys, +28

Clinical Cancer Research

Synthetic lethality between Rb, p53 and Dicer or miR-17–92 in retinal progenitors suppresses retinoblastoma formation

David Nittner, Irina Lambertz, Frederic F. Clermont, +10

Nature Cell Biology

Retinal BiologyRetinaCell RegulationOphthalmologyMedicine +9

<i>Dickkopf‐3</i> is regulated by the MYCN‐induced miR‐17‐92 cluster in neuroblastoma

Sara De Brouwer, Pieter Mestdagh, Irina Lambertz, +9

International Journal of Cancer

PathologyCancer BiologyMycn ExpressionTumor BiologyCancer Cell Biology +14

The ETS transcription factor ETV5 is a target of activated ALK in neuroblastoma contributing to increased tumour aggressiveness

Liselot Mus, Irina Lambertz, Shana Claeys, +17

Scientific Reports